About BillionToOne
What BillionToOne is building
Technologies used at BillionToOne
Python
SQL
AWSCompany culture
WE CHALLENGE
The status quo that makes healthcare expensive, opaque and out of reach for the majority
Funding rounds
Total Funding
Last funding round type
Company type
BillionToOne news and updates
BillionToOne, Inc. launches follow-on validation study
BillionToOne has already launched a follow-on validation study, for which it is gathering data, and hopes to eventually win inclusion of Unity into clinical guidelines.
Dec 15, 2022 | genomeweb.comBillionToOne, Inc. hires Tom Lynch as general counsel and chief compliance officer
Molecular diagnostics developer BillionToOne has appointed Tom Lynch as general counsel and chief compliance officer.
Dec 1, 2022 | genomeweb.comBillionToOne, Inc. launches UNITY fetal antigen single-gene non-invasive prenatal test
BillionToOne, Inc., a molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all, announces the launch of their UNITY fetal antigen single-gene non-invasive prenatal test (sgNIPT), a new... Sign up to receive Biotech Networks Briefs trending news and featured jobs monthly, with 2-3 additional partner offers per month.
Sep 29, 2022 | sfbn.orgTech Startups partnered with BillionToOne, Inc. on Jan 1st 19'.
“Tech Startups has partnered with BillionToOne since their Series A in 2019, and it has been incredible to witness the Company’s tremendous growth and unparalleled execution.
Jan 1, 2022 | techstartups.comNsmedicaldevices partnered with BillionToOne, Inc. on Jan 1st 19'.
“Nsmedicaldevices has partnered with BillionToOne since their Series A in 2019, and it has been incredible to witness the Company’s tremendous growth and unparalleled execution.
Jan 1, 2022 | nsmedicaldevices.comSilicon Valley Daily partnered with BillionToOne, Inc. on Jan 1st 19'.
“Silicon Valley Daily has partnered with BillionToOne since their Series A in 2019, and it has been incredible to witness the Company’s tremendous growth and unparalleled execution.
Jan 1, 2022 | svdaily.comBillionToOne, Inc. launches oncology liquid biopsy products, Northstar Select and Northstar Response
BillionToOne, Inc., a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all, announces the launch of its first oncology liquid biopsy products, Northstar Select™ and Northstar Response™.
Jan 1, 2022 | prnewswire.comBillionToOne Appoints Nipun Soni, CFA, CPA as the First Chief Financial Officer
BillionToOne, Inc., the precision diagnostics company announced today the appointment of Nipun Soni, CFA, CPA as the first Chief Financial Officer.
Jun 15, 2021 | PR NewswireBillionToOne, Inc. launches YC Breakthrough Companies list
In addition to the list of top companies, BillionToOne, Inc. also launched the YC Breakthrough Companies list to highlight the fast-growing startups that have received between $15M-$300M from YC.
Jan 1, 2021 | ycombinator.comBillionToOne, Inc. received financing of $55M in Series B funding round on Mar 30th 21'.
BillionToOne said Monday that it has closed a $55 million oversubscribed Series B funding round.
Jan 1, 2021 | genomeweb.comBillionToOne secures EUA for RNA extraction-free Covid-19 test
Precision diagnostics company BillionToOne has received emergency use authorisation (EUA) from the US Food and Drug Administration (FDA) for its Covid-19 diagnostic test, which doesn’t require RNA extraction.
Sep 8, 2020 | Medical Device NetworkBillionToOne, Inc., announced today that it has closed its follow-on Series A+ funding round of $15 million
BillionToOne has raised more than $32.5 million. The funding will be used to support the commercial expansion of UNITY™ to all US states
May 10, 2020 | PR NewswireBillionToOne, Inc. receives financing of $32.5M in funding
This brings the total funding that BillionToOne has raised to more than $32.5 million.
Jan 1, 2020 | ptcommunity.comBillionToOne, Inc. received financing of $15M in Series A+ funding round on Mar 10th 20'.
BillionToOne says it has closed a highly oversubscribed Series A funding round of $15 million.
Jan 1, 2020 | qb3.org